Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 57 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

28%

16 trials in Phase 3/4

Results Transparency

7%

1 of 14 completed trials have results

Key Signals

7 recruiting1 with results

Enrollment Performance

Analytics

N/A
22(45.8%)
Phase 4
14(29.2%)
Phase 2
5(10.4%)
Phase 1
5(10.4%)
Phase 3
2(4.2%)
48Total
N/A(22)
Phase 4(14)
Phase 2(5)
Phase 1(5)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (57)

Showing 20 of 57 trials
NCT07348965Not ApplicableRecruiting

Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal Metastasis

Role: lead

NCT05378334Not ApplicableRecruiting

Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients

Role: lead

NCT07337096Not ApplicableNot Yet Recruiting

Electro-Acupuncture in Lung cancER : EALER Study

Role: lead

NCT07338396Not Yet Recruiting

A Prospective Multicenter Study of the Association Between TCM Syndromes and EGFR-TKI Efficacy in Lung Cancer Patients

Role: lead

NCT06461338Not ApplicableActive Not Recruiting

Acupuncture for Enhancing Immunotherapy in Advanced NSCLC:a Pilot Study

Role: lead

NCT07121088Phase 4Not Yet Recruiting

Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study

Role: lead

NCT07120724Recruiting

Real-World Study on Chinese Medicine for Treating Chikungunya Fever

Role: lead

NCT07104422Not Yet Recruiting

An Epidemiological and Long-Term Endpoint Registry Study on Disease-Syndrome Correlation Patterns in Comorbid Population With Diabetes and Ischemic Cardio-Cerebrovascular Disease

Role: lead

NCT07098949Not ApplicableNot Yet Recruiting

Acupuncture Combined With Chemotherapy for Gastric Cancer After Surgery

Role: lead

NCT07088523Phase 4Not Yet Recruiting

Traditional Chinese Medicine Intervention for Ischemic Cardiovascular Disease Comorbid With Diabetes Mellitus: An Efficacy Comparative Study

Role: lead

NCT06055179Not ApplicableRecruiting

XCHT for Irinotecan-Induced Gut Toxicities (Randomized Controlled Trial)

Role: lead

NCT06609070Not ApplicableNot Yet Recruiting

CHG0521 Oral Coating in Patients with Solid Tissue Tumor/Recurrent/Metastatic TSCC

Role: lead

NCT04926545Not ApplicableCompleted

XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)

Role: lead

NCT04360577Not ApplicableCompleted

Acupuncture for QoL and Symptoms in Gastric Cancer During Adjuvant Chemotherapy

Role: lead

NCT06255379Phase 2Not Yet Recruiting

Study of Fruquintinib Combined With Tegafur Gimeracil Oteracil in Patients With Metastatic Colorectal Cancer

Role: lead

NCT06277674Phase 2Recruiting

Efficacy of Cadonilimab in Non-squamous Non-small Cell Lung Cancer Patients Resistant to EGFR-TKI

Role: lead

NCT05483595Not ApplicableCompleted

An Examination of Blinding for Chinese Herbal Oral Liquid and Matched Placebo

Role: lead

NCT06161298Unknown

Microbe-host Interaction Relationship in Patients With Stroke-relatedPneumonia

Role: lead

NCT05622877Phase 1Unknown

The Proteomic Study and Early Intervention Study of Carotid Unstable Plaque

Role: lead

NCT05315895Recruiting

The Dampness Syndrome of Chinese Medicine Cohort Study

Role: lead